학술논문

Efficacy and safety of lebrikizumab in patients with uncontrolled asthma (LAVOLTA I and LAVOLTA II): replicate, phase 3, randomised, double-blind, placebo-controlled trials
Document Type
Article
Source
In The Lancet Respiratory Medicine October 2016 4(10):781-796
Subject
Primary Research
Articles
Language
ISSN
2213-2600